Axikin Pharmaceuticals
Axikin
In the News

July 10, 2013 - Axikin Pharmaceuticals receives No Objection Letter for Phase 2 study of AXP1275 in Canada. More

July 20, 2012 - Axikin Pharmaceuticals submits IND for AXP1275. More

driven by rightturn